Intelligence · Clinical Pipeline
Vanda Pharmaceuticals Netherlands Pipeline
All ClinicalTrials.gov programs at Vanda Pharmaceuticals Netherlands — phase, modality, and trial IDs.
- Programs
- 60
Quick answer
Vanda Pharmaceuticals Netherlands has 60 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
VHX-896 and iloperidone
Vanda Pharmaceuticals Netherlands B.V.
Healthy
1 trial -
VHX-896 and iloperidone
Vanda Pharmaceuticals Netherlands B.V.
Schizophrenia
1 trial -
VLY-686
Vanda Pharmaceuticals Netherlands B.V.
Pruritus
1 trial -
iloperidone (oral tablet)
Vanda Pharmaceuticals Netherlands B.V.
Safety and Tolerability of Iloperidone
1 trial -
tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Circadian Rhythm Sleep Disorders
1 trial -
tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Hepatic Impairment
1 trial -
tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Healthy
1 trial -
tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Pharmacodyamics and Pharmacokinetics of Tasimelteon Alone and in Combination With Ethanol
1 trial -
tradipitant
Vanda Pharmaceuticals Netherlands B.V.
Healthy Volunteers
1 trial -
Iloperidone
Vanda Pharmaceuticals Netherlands B.V.
Schizophrenia
5 trials -
iloperidone
Vanda Pharmaceuticals Netherlands B.V.
Bipolar Disorder
1 trial -
tasimelteon 20 mg capsule
Vanda Pharmaceuticals Netherlands B.V.
Non-24-Hour-Sleep-Wake Disorder
1 trial
Frequently asked questions
How many pipeline programs does Vanda Pharmaceuticals Netherlands have?
60 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs